Duration of depressive symptoms and mortality risk: the English Longitudinal Study of Ageing (ELSA)

Br J Psychiatry. 2016 Apr;208(4):337-42. doi: 10.1192/bjp.bp.114.155333. Epub 2016 Jan 21.

Abstract

Background: The relationship between the duration of depressive symptoms and mortality remains poorly understood.

Aims: To examine whether the duration of depressive symptoms is associated with mortality risk.

Method: Data (n= 9560) came from the English Longitudinal Study of Ageing (ELSA). We assessed depressive symptom duration as the sum of examinations with an eight-item Center for Epidemiologic Studies Depression Scale score of ⩾3; we ascertained mortality from linking our data to a national register.

Results: Relative to those participants who never reported symptoms, the age- and gender-adjusted hazard ratios for elevated depressive symptoms over 1, 2, 3 and 4 examinations were 1.41 (95% CI 1.15-1.74), 1.80 (95% CI 1.44-2.26), 1.97 (95% CI 1.57-2.47) and 2.48 (95% CI 1.90-3.23), respectively (Pfor trend <0.001). This graded association can be explained largely by differences in physical activity, cognitive function, functional impairments and physical illness.

Conclusions: In this cohort of older adults, the duration of depressive symptoms was associated with mortality in a dose-response manner.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging*
  • Case-Control Studies
  • Depression / diagnosis*
  • Depression / mortality*
  • England
  • Female
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Registries
  • Risk Factors
  • Time Factors